Study of Tiotropium Hydrofluoralkane in Patients With Chronic Obstructive Pulmonary Disease
- Study Title
- A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease
- Teva Identifier
- TBB-COPD-20009
- ClinicalTrials.gov Identifier
- NCT02203474
- Study Status
- Withdrawn
- Trial Condition(s)
- Chronic Obstructive Pulmonary Disease | COPD
- Interventions
- Drug: Tiotropium HFA BAI 5 mcg | Drug: Tiotropium 18 mcg Capsule | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 40 Years to 80 Years
- Trial Duration
- 08/01/2014 - 08/01/2014
- Phase
- Phase 2
